News
LRF Publishes Recommendations on Adolescent and Young Adult Lymphoma Research
Findings from the 2015 Lymphoma Research Foundation scientific symposium on adolescent/young adult (AYA) lymphomas have…
More than 100 Buildings Worldwide Will Join the Lymphoma Research Foundation to Light Red to Raise Awareness for Blood Cancer
Lymphoma Research Foundation’s Premier Light it Red for Lymphoma Initiative Expected to Reach Millions During…
FDA Approves Ibrutinib to Treat Chronic Graft Versus Host Disease
New York, NY (August 3, 2017) – New York, NY – The U.S. Food and…
Lymphoma Research Foundation Makes Additional $700,000 Investment in Young Investigators
Lymphoma Research Foundation Announces Scientific Advisory Board Chair Thomas M. Habermann for FY 2018-2019
The Nation’s Premier Lymphoma-Specific Research Organization Also Adds Four Experts to Industry Leading SAB New…
FDA Approves Subcutaneous Rituximab for Treatment of Various Lymphomas
New York, NY (June 5, 2017) – The U.S. Food and Drug Administration (FDA) announced…
Second Annual Swirl: Chicago Wine Tasting Event Raises More Than $105,000
Local wine and food patrons gather in support of the Lymphoma Research Foundation’s mission Chicago,…
Lymphoma Research Foundation Awards More than $1 Million In Young Investigator Grants at Forefront of Lymphoma Research
Applications for 2018 research grants are now open and will be accepted until September The…
FDA Approves Pembrolizumab (KEYTRUDA®) for Classical Hodgkin Lymphoma
New York, NY (March 14, 2017) – The U.S. Food and Drug Administration (FDA) announced…